Investor Presentations & Notice of Trading Update | 02-Jun-2025 | 07:00 | RNS |
Holding(s) in Company | 30-May-2025 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 16-May-2025 | 07:00 | RNS |
CFO succession planning | 15-May-2025 | 07:00 | RNS |
FDA clearance for Tristel OPH | 12-May-2025 | 07:00 | RNS |
Additional info. submitted to FDA for Tristel OPH | 10-Apr-2025 | 07:00 | RNS |
Publication of Poster by Mayo Clinic & US update | 09-Apr-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 02-Apr-2025 | 07:00 | RNS |
Holding(s) in Company | 31-Mar-2025 | 08:56 | RNS |
Director/PDMR Shareholding | 26-Mar-2025 | 10:30 | RNS |
Holding(s) in Company | 18-Mar-2025 | 14:39 | RNS |
Unaudited Interim Results | 24-Feb-2025 | 07:00 | RNS |
Exercise of Share Options and Total Voting Rights | 07-Feb-2025 | 07:00 | RNS |
Director Option Grant | 23-Jan-2025 | 07:00 | RNS |
Confirmation of Interim Results | 13-Jan-2025 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 345.00p |
Change Today | -7.00p |
% Change | -1.99 % |
52 Week High | 500.00p |
52 Week Low | 270.00p |
Volume | 108,652 |
Shares Issued | 47.71m |
Market Cap | £164.61m |
RiskGrade | 180 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 2 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Interim | Final | |
Ex-Div | 20-Mar-25 | 28-Nov-24 |
Paid | 11-Apr-25 | 20-Dec-24 |
Amount | 5.68p | 8.28p |
Time | Volume / Share Price |
14:41 | 40,963 @ 341.22p |
16:33 | 635 @ 352.79p |
16:26 | 2,417 @ 344.50p |
16:19 | 1,000 @ 344.50p |
15:56 | 300 @ 345.00p |
Finance Director | Elizabeth Dixon |
CEO | Matthew (Matt) Giovanni Sassone |
You are here: research